Prevalent Coronary Artery Disease and Undertreatment in Heterozygous Familial Hypercholesterolemia -Real-World Data and “Heterozygous FH Score” from FAME Study--Reference-Cited by-同舟云学术

Prevalent Coronary Artery Disease and Undertreatment in Heterozygous Familial Hypercholesterolemia -Real-World Data and “Heterozygous FH Score” from FAME Study-

Published:2022-05-01 Issue:5 Volume:29 Page:567-570
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Nohara Atsushi¹

Affiliation:

1. Department of Clinical Genetics, Ishikawa Prefectural Central Hospital, Kanazawa, Japan

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/29/5/29_ED199/_pdf

Reference15 articles.

1. 1) Mabuchi H. Half a Century Tales of Familial Hypercholesterolemia (FH) in Japan. J Atheroscler Thromb, 2017; 24: 189-207

2. 2) Harada-Shiba M, Arai H, Ishigaki Y, Ishibashi S, Okamura T, Ogura M, Dobashi K, Nohara A, Bujo H, Miyauchi K, Yamashita S, Yokote K and Working Group by Japan Atherosclerosis Society for Making Guidance of Familial H. Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017. J Atheroscler Thromb, 2018; 25: 751-770

3. 3) Tada H, Okada H, Nomura A, Usui S, Sakata K, Nohara A, Yamagishi M, Takamura M and Kawashiri MA. Clinical Diagnostic Criteria of Familial Hypercholesterolemia- A Comparison of the Japan Atherosclerosis Society and Dutch Lipid Clinic Network Criteria. Circ J, 2021; 85: 891-897

4. 4) Casula M, Olmastroni E, Pirillo A, Catapano AL, Members Of The Lipigen Steering C, center PIC, Participant C, Participant L, Collaborators, Study Central L and Analysis G. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study. Atherosclerosis, 2018; 277: 413-418

5. 5) Mabuchi H, Ito S, Haba T, Ueda K and Ueda R. Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by Achilles’ tendon thickness. Atherosclerosis, 1977; 28: 61-68